Hansoh Pharmaceutical (03692): Enters into Strategic Collaboration and License Agreement with Roche

Zhitong Finance APP News, Hansoh Pharmaceutical (03692) announced that on October 17, 2026, the Company's wholly-owned subsidiaries Shanghai Hansoh Biomedical Technology Co., Ltd., Changzhou Hengbang Pharmaceutical Co., Ltd., and Hansoh Bio, LLC (collectively "Hansoh"), entered into a strategic collaboration and license agreement with F. Hoffmann-La Roche Ltd (Roche).